Ascending Dose Study of HU6 in Healthy Volunteers

Completed · Phase 1 · Has a placebo group

Conditions studied: NASH - Nonalcoholic Steatohepatitis

In brief

This is a single ascending dose trial in healthy volunteers. The study will be conducted in up to 7 cohorts. Upon review of the safety and PK data, it may be decided to expand the current cohort versus dose escalate to the next cohort. In addition, the sponsor may elect not to enroll all 7 cohorts based on safety and/or PK and/or PD data.

Key facts

Study ID

NCT04463017

Run by

Rivus Pharmaceuticals, Inc.

People needed

64

Starts

2020-08-12

Expected to finish

2021-04-01

Last updated by the study team

2021-05-04

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.

Where it is running

• Prism Clinical Research — Saint Paul, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.